Transcription of User Access Management CTIS Training Programme Module 03
{{id}} {{{paragraph}}}
FAQs User Access Management CTIS Training Programme Module 03. Version January 2022. What you will find Answers to common questions regarding User Access Management in CTIS. An overview categorised in questions of a general nature and questions related to the processes of self-registration, login to CTIS, basic roles and permissions in CTIS, user profile Management and organisations. European Medicines Agency, 2021. Reproduction and/or distribution of the content of these Training materials for non-commercial or commercial purposes is authorised, provided the European Medicines Agency is acknowledged as the source of the materials. The European Medicines Agency developed this Training material to enhance public Access to information on the Clinical Trial Information System (CTIS). This material describes a preliminary version of CTIS and may therefore not entirely describe the system as it is at the time of use of this material.
on their e-mail box as it could be stored there automatically. In case users have not received the confirmation e-mail, they can call the EMA Service Desk telephone number: +31 (0) 88781 7523. 2.5. Does the self-registration need to be validated by someone before users get access to a secured workspace in CTIS? .
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}